Dunnick June K, Nyska Abraham
National Institute of Environmental Health Sciences, Research Triangle Park, P.O. Box 12233, NC 27709, USA.
Exp Toxicol Pathol. 2009 Jan;61(1):1-12. doi: 10.1016/j.etp.2008.06.008. Epub 2008 Sep 6.
Lower molecular weight polybrominated diphenyl ethers (PBDEs), components of flame retardants, are found in the environment and in human and animal tissues. Toxicity studies were conducted in F344/N rats and B6C3F1 mice by administering a flame retardant containing these lower molecular weight PBDEs (BDE-47, BDE-99, BDE-100, and BDE153) by oral gavage 5 days/week for 13 weeks at doses of 0.01, 5, 50, 100 or 500mg/kg/day. Liver was the primary target organ in rats and mice. Treatment-related increases in liver weights, liver cytochrome P450 (1A1, 1A2, 2B) and UDPGT (rats only) levels, and liver lesions were seen in both rats and mice. Hepatocyte hypertrophy and vacuolization increased in incidence and severity with treatment, and occurred at levels of 50mg/kg and above in rats, and at 100mg/kg and above in mice. Liver Cyp 1A1, 1A2, and 2B levels were increased at exposure levels of 50mg/kg and above in rats and mice. In addition, treatment-related thyroid lesions occurred particularly in rats. The most sensitive parameter for PBDE toxicity was the increase in liver weights which occurred at 5mg/kg above in rats and 50mg/kg and above in mice. These results suggest that liver may be a target organ for carcinogenesis processes after long-term administration of PBDEs. A chronic PBDE study is currently being conducted by the National Toxicology Program.
低分子量多溴二苯醚(PBDEs)是阻燃剂的成分,存在于环境以及人类和动物组织中。在F344/N大鼠和B6C3F1小鼠中进行了毒性研究,通过每周5天经口灌胃给予含有这些低分子量PBDEs(BDE - 47、BDE - 99、BDE - 100和BDE153)的阻燃剂,持续13周,剂量为0.01、5、50、100或500mg/kg/天。肝脏是大鼠和小鼠的主要靶器官。在大鼠和小鼠中均观察到与治疗相关的肝脏重量增加、肝脏细胞色素P450(1A1、1A2、2B)和UDPGT(仅在大鼠中)水平升高以及肝脏病变。肝细胞肥大和空泡化的发生率和严重程度随治疗而增加,在大鼠中50mg/kg及以上剂量时出现,在小鼠中100mg/kg及以上剂量时出现。大鼠和小鼠在暴露水平为50mg/kg及以上时肝脏Cyp 1A1、1A2和2B水平升高。此外,与治疗相关的甲状腺病变尤其在大鼠中出现。PBDE毒性最敏感的参数是肝脏重量增加,在大鼠中5mg/kg及以上剂量时出现,在小鼠中50mg/kg及以上剂量时出现。这些结果表明,长期给予PBDEs后肝脏可能是致癌过程的靶器官。国家毒理学计划目前正在进行一项慢性PBDE研究。